Prostate Cancer ADT Found to Increase Depression Risk
Men who receive androgen deprivation therapy after radical prostatectomy have a nearly 2-fold increased risk of depression compared with those who receive no post-surgical treatment.
All articles by John Schieszer
Adverse Events in Randomized Clinical Trials for Targeted Therapies High in Placebo Groups
Researchers conducted a meta-analysis to determine the incidence of adverse events among patients assigned to placebo-receiving groups in randomized clinical trials.
Overtreatment a Concern With RAI for Well-Differentiated Thyroid Cancer
In a study from the Cleveland Clinic, researchers investigated the association between well-differentiated thyroid cancer and risk for AML or CML in those patients treated with radioactive iodine.
Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
Regular aspirin use is associated with a lower risk of breast cancer among women with diabetes, a recent study from Taiwan has shown.
Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
E-cigarettes used with nicotine-based liquid have the same potential to produce cancer-causing DNA damage as unfiltered regular cigarettes.
Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
Immunotherapy regimens FDA-approved for the treatment of melanoma may also be an option for a rare and aggressive form of papillary thyroid cancer.
Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
Adding a second HER2-blocker to standard care therapy after surgery for HER2-positive breast cancer may be modestly beneficial for some women.
Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
A survey of men with prostate cancer revealed that treatment-related factors impact treatment decisions differently in black men compared with white men.
New treatments are improving outcomes in melanoma
Targeted therapy, combination therapies, vaccines, and new treatment modalities demonstrate promising prognoses for these patients.
Next post in Melanoma
